Genmab's SWOT analysis: biotech firm's stock faces growth and integration challenges
Genmab (NASDAQ:GMAB), a biotechnology company with a market capitalization of $16.91 billion specializing in cancer ...
Barchart on MSN30m
What to Expect From Verisk Analytics’ Q4 2024 Earnings Report
Jersey City, New Jersey-based Verisk Analytics, Inc. (VRSK) provides data analytics and technology solutions to the insurance markets. Valued at a market cap of $39.4 billion, the company offers ...
Private home prices jumped 2.3 per cent in Q4 2024 on November’s new sales
The private residential price index grew 3.9 per cent in 2024, the slowest annual price growth recorded since 2020 Read more at straitstimes.com.